ALGN
NasdaqALIGN TECHNOLOGY INC
Health Care, Health Care Supplies
$173.66
close 7 Aug 2026
+28.81%
52-week change
$12.37B
market cap
$122.00
$200.44
52-week range
| Line item | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||||||||||||
| Revenue | $4.14B | $4.03B | $4.00B | $3.86B | $3.73B | $3.95B | $2.47B | $2.41B | $1.97B | $1.47B | $1.08B | $845.49M | $761.65M | $660.21M | $560.04M | $479.74M | $387.13M | $312.33M | $303.98M |
| Cost of revenue | $1.32B | $1.32B | $1.20B | $1.16B | $1.10B | $1.02B | $708.71M | $662.90M | $518.63M | $356.47M | $264.58M | $205.38M | $183.21M | $162.10M | $143.65M | $118.46M | $83.71M | $78.84M | $78.85M |
| Gross profit | $2.82B | $2.71B | $2.80B | $2.71B | $2.63B | $2.94B | $1.76B | $1.74B | $1.45B | $1.12B | $815.29M | $640.11M | $578.44M | $498.11M | $416.39M | $361.28M | $303.42M | $233.49M | $225.13M |
| R&D | $377.00M | $369.91M | $364.20M | $346.83M | $305.26M | $250.32M | $175.31M | $157.36M | $128.90M | $97.56M | $75.72M | $61.24M | $52.80M | $44.08M | $42.87M | $37.15M | $26.00M | $22.25M | $26.17M |
| SG&A | $1.79B | $1.76B | $1.76B | $1.70B | $1.67B | $1.71B | $1.20B | $1.07B | $852.40M | $665.78M | $490.65M | $390.24M | $332.07M | $292.80M | $99.30M | $91.60M | $64.79M | $61.72M | $62.15M |
| Operating income | $547.59M | $545.76M | $607.63M | $643.34M | $642.60M | $976.40M | $387.17M | $542.49M | $466.56M | $353.61M | $248.92M | $188.63M | $193.58M | $94.21M | $85.59M | $90.36M | $102.73M | -$34.01M | $15.51M |
| Interest expense | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $51.00K | $19.00K | $85.00K | $24.00K |
| Tax expense | $155.33M | $174.94M | $187.60M | $196.15M | $237.48M | $240.40M | -$1.40B | $112.35M | $57.72M | $130.16M | $51.20M | $42.08M | $44.54M | $28.84M | $25.61M | $23.23M | $27.75M | -$2.62M | -$62.91M |
| Net income | $413.58M | $410.35M | $421.36M | $445.05M | $361.57M | $772.02M | $1.78B | $442.78M | $400.24M | $231.42M | $189.68M | $144.02M | $145.83M | $64.30M | $58.69M | $66.72M | $74.25M | -$31.27M | $79.99M |
| Diluted EPS | $5.74 | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 | $22.41 | $5.53 | $4.92 | $2.83 | $2.33 | $1.77 | $1.77 | $0.7800 | $0.7100 | $0.8300 | $0.9500 | -$0.4500 | $1.18 |
| Gross margin | 68.05% | 67.19% | 70.00% | 70.08% | 70.52% | 74.26% | 71.33% | 72.46% | 73.63% | 75.81% | 75.50% | 75.71% | 75.95% | 75.45% | 74.35% | 75.31% | 78.38% | 74.76% | 74.06% |
| Operating margin | 13.23% | 13.53% | 15.19% | 16.66% | 17.21% | 24.70% | 15.66% | 22.54% | 23.73% | 24.00% | 23.05% | 22.31% | 25.42% | 14.27% | 15.28% | 18.84% | 26.54% | -10.89% | 5.10% |
| Net margin | 9.99% | 10.17% | 10.54% | 11.52% | 9.68% | 19.53% | 71.84% | 18.40% | 20.35% | 15.71% | 17.57% | 17.03% | 19.15% | 9.74% | 10.48% | 13.91% | 19.18% | -10.01% | 26.31% |
filed 5 Aug 2026